Nuveen Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$35.9M Buy
3,807,420
+159,139
+4% +$1.5M 0.01% 821
2024
Q3
$39M Buy
3,648,281
+1,748,774
+92% +$18.7M 0.01% 786
2024
Q2
$18.8M Buy
1,899,507
+751,963
+66% +$7.46M 0.01% 1167
2024
Q1
$13.5M Sell
1,147,544
-255,028
-18% -$3M ﹤0.01% 1415
2023
Q4
$19.9M Buy
1,402,572
+161,746
+13% +$2.3M 0.01% 1163
2023
Q3
$15.1M Buy
1,240,826
+426,144
+52% +$5.18M 0.01% 1221
2023
Q2
$10.2M Buy
814,682
+4,476
+0.6% +$56.2K ﹤0.01% 1493
2023
Q1
$8.99M Sell
810,206
-165,086
-17% -$1.83M ﹤0.01% 1553
2022
Q4
$11.9M Sell
975,292
-155,443
-14% -$1.9M ﹤0.01% 1378
2022
Q3
$11.8M Sell
1,130,735
-131,828
-10% -$1.38M ﹤0.01% 1376
2022
Q2
$13.6M Buy
1,262,563
+169,893
+16% +$1.82M 0.01% 1322
2022
Q1
$10.5M Sell
1,092,670
-375,481
-26% -$3.61M ﹤0.01% 1613
2021
Q4
$15M Sell
1,468,151
-157,321
-10% -$1.61M ﹤0.01% 1425
2021
Q3
$17.9M Sell
1,625,472
-310,165
-16% -$3.41M 0.01% 1346
2021
Q2
$18.7M Sell
1,935,637
-346,769
-15% -$3.34M 0.01% 1423
2021
Q1
$22.6M Sell
2,282,406
-378,628
-14% -$3.74M 0.01% 1228
2020
Q4
$61.4M Sell
2,661,034
-36,009
-1% -$831K 0.02% 596
2020
Q3
$38.1M Sell
2,697,043
-205,939
-7% -$2.91M 0.01% 687
2020
Q2
$43.8M Sell
2,902,982
-130,178
-4% -$1.96M 0.02% 598
2020
Q1
$28M Sell
3,033,160
-1,121,611
-27% -$10.4M 0.01% 719
2019
Q4
$40.5M Buy
4,154,771
+2,000,176
+93% +$19.5M 0.02% 780
2019
Q3
$17.3M Sell
2,154,595
-797,926
-27% -$6.4M 0.01% 1218
2019
Q2
$36.8M Buy
+2,952,521
New +$36.8M 0.01% 837
2017
Q1
Sell
-10,341
Closed -$51K 1394
2016
Q4
$51K Buy
+10,341
New +$51K ﹤0.01% 1455